SCHEMBL10138469

SCHEMBL10138469

CCCOCCOCCCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.52
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
TSHR P16473 5/20 0.50
HDAC11 Q96DB2 5/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 3/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
KMT2A Q03164 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50
PDE3A Q14432 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31151079 1.00 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL448526 0.98 AKR1B1 (0.54) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL9503728 0.95 AKR1B1 (0.52) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL20725734 0.93 AKR1B1 (0.56) AKR1B1GPR84PPARGPPARDPPARA
Adipic Acid SCHEMBL4796929 0.93 AKR1B1 (0.61) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL17909689 0.91 AKR1B1 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL17908712 0.91 AKR1B1 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL380287 0.91 AKR1B1 (0.58) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL448062 0.91 AKR1B1 (0.58) AKR1B1GPR84PPARGPPARDPPARA
Adipic Acid SCHEMBL12980712 0.91 AKR1B1 (0.64) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150974-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed
EP-3441382-A1 OXA ACID COMPOUND Moresco Corporation (JP) 2019-02-13 EP disclosed
US-20130310912-A1 COVALENT MODIFICATION OF METAL SURFACES INTEZYNE TECHNOLOGIES (US) 2013-11-21 US disclosed
US-20120046735-A1 PLASMA MODIFICATION OF METAL SURFACES INTEZYNE TECHNOLOGIES, INCORPORATED (US) 2012-02-23 US disclosed
US-20120046757-A1 COVALENT MODIFICATION OF METAL SURFACES INTEZYNE TECHNOLOGIES (US) 2012-02-23 US disclosed
US-8066824-B2 Covalent modification of metal surfaces INTEZYNE TECHNOLOGIES, INC. (US) 2011-11-29 US disclosed
US-20080035243-A1 Covalent modification of metal surfaces INTEZYNE TECHNOLOGIES (US) 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080035243-A1 Covalent modification of metal surfaces ITGAL, ITGA1, ITGA5 AKR1B1 4523/4885GPR84 4390/4885PPARG 2943/4885
US-20230150974-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB AKR1B1 2751/4885GPR84 4504/4885PPARG 309/4885
US-20120046757-A1 COVALENT MODIFICATION OF METAL SURFACES ITGAL, ITGA1, ITGA5 AKR1B1 4523/4885GPR84 4390/4885PPARG 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.